-
Large-Scale Genome Editing Technology in Development
Two biotechnology companies are creating an automated process for delivering large, complex genetic cargoes into cells for genome editing.
-
Your Business’s Tech: A Blessing Or A Curse?
A lot of people simply aren’t sure just how much of a benefit or drawback embracing tech in their business can be. The truth is that it’s a little bit of both much of the time.
-
Infographic – Patenting Among Top Tech Companies
CB Insights compiled a recent research brief with a chart showing where the top five technology companies — Google, Amazon, Facebook, Apple, and Microsoft — are placing their bets with new patent applications.
-
Happy Thanksgiving 2017
23 November 2017. Today is our Thanksgiving holiday in the U.S., a day of family gatherings, feasting, football, and in New York, the Macy’s Thanksgiving Day parade. We have our own tradition here at Science & Enterprise, Arlo Guthrie’s singing of Alice’s Restaurant, a story about Thanksgiving and a whole lot more. The video is…
-
Will We Live To See Mars Colonized?
Humanity has overcome some pretty steep odds in the past, so who knows. Is colonizing Mars actually viable?
-
Rapid DNA, RNA Capture Technique Devised
Researchers in Australia developed a simple and inexpensive dipstick technique that captures and purifies specimen samples for genetic analysis in about 30 seconds.
-
Genome Editing Enhances CAR T-Cells to Fight Cancer
A process using genome editing is shown to bolster cancer-fighting properties of T-cells from the immune system already modified to attack cancer cells.
-
Simple Blood Test System Detects Brain Injuries
An engineering team at Purdue University designed a system that detects indicators of traumatic brain injuries in lab tests with one or two drops of blood.
-
Biotech, Cancer Center Partner on T-Cell Research
A developer of cancer diagnostics and treatments is collaborating with Moffitt Cancer Center to advance therapies for ovarian cancer with T-cells from the immune system.
-
Bayer Acquiring Therapeutic Peptides in $1.1B+ Deal
Bayer AG, the global drug maker and agricultural chemical company, is partnering with a Japanese biologics enterprise to discover a series of peptides for therapies.